secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2021-08-20T23:59:59+00:00
Accession:  0000200406-21-000061
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alex Gorsky to step down as JNJ CEO Jan 3, 2022; Joaquin Duato named successor
------------------------------------------------------------------------------

- Alex Gorsky will transition from CEO to Executive Chairman effective Jan 3, 2022, citing family health reasons.
- Joaquin Duato, currently Vice Chairman of Executive Committee, becomes CEO and joins Board on Jan 3, 2022.
- Under Gorsky, R&D investment rose 60% to $12B, adjusted EPS increased ~85%, and market cap grew from ~$180B to ~$470B.
- Duato has been with JNJ since 1989, led Pharma transformation, and oversaw COVID-19 response and supply chain continuity.
- Board cites long-term succession planning; Duato is 'uniquely qualified' to lead.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040621000061/0000200406-21-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040621000061/jnj-20210819.htm
  HTML page:      https://secwatch.observer/filing/0000200406-21-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer